PLAINSBORO, N.J., March 12, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Monday, April 16, 2007 at 10:00 AM Eastern Time at the Hilton Garden Inn in Washington, D.C. The meeting will be hosted by Stuart Essig, Integra LifeSciences' President and Chief Executive Officer. Integra's senior research, sales and marketing personnel will lead presentations on the neurosurgery and spine products that are expected to drive future growth. A question and answer session will follow the formal presentations.
The Analyst Forum is open to all analysts and investors. Those who wish to attend the Analyst Forum in person should send an email to the attention of Kimberly O'Rourke (Kimberly.orourke@Integra-LS.com) by April 2, 2007 requesting a reservation to attend in person. Access to the live presentations will be available by dialing (913) 312-1233 or through a listen-only webcast via a link provided on the investor relations home page of our website at http://www.Integra-LS.com. Listeners participating via telephone or webcast will not be able to ask questions during the question and answer session.
A replay of the Analyst Forum will be accessible starting one hour following the live event. Access to the replay will be available through April 30, 2007 by dialing (719) 457-0820 (access code 7314971) or through the webcast accessible on the investor relations home page of our website.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (http://www.Integra-LS.com).
Statements made in the upcoming Analyst Forum may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. Forward-looking factors that may be discussed include, but are not limited to, expected financial results, new product development, governmental approvals, market potential, and expected sales and potential therapeutic applications of new products. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in the Business section of Integra's Annual Report on Form 10-K for the year ended December 31, 2006 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice President
Chief Administrative Officer
John Bostjancic, Vice President of Corporate Development
and Investor Relations